Noa Kaynan

613 total citations
26 papers, 471 citations indexed

About

Noa Kaynan is a scholar working on Biomedical Engineering, Molecular Biology and Immunology. According to data from OpenAlex, Noa Kaynan has authored 26 papers receiving a total of 471 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Biomedical Engineering, 8 papers in Molecular Biology and 8 papers in Immunology. Recurrent topics in Noa Kaynan's work include Nanoplatforms for cancer theranostics (11 papers), 3D Printing in Biomedical Research (7 papers) and RNA Interference and Gene Delivery (6 papers). Noa Kaynan is often cited by papers focused on Nanoplatforms for cancer theranostics (11 papers), 3D Printing in Biomedical Research (7 papers) and RNA Interference and Gene Delivery (6 papers). Noa Kaynan collaborates with scholars based in Israel, Germany and Switzerland. Noa Kaynan's co-authors include Moshe Giladi, Tali Voloshin, Rosa S. Schneiderman, Yoram Palti, Uri Weinberg, Einav Zeevi, Eilon D. Kirson, Anna Shteingauz, Mijal Munster and Yaara Porat and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Noa Kaynan

25 papers receiving 463 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Noa Kaynan Israel	9	162	143	122	121	109	26	471
Roni Blat Switzerland	7	295 1.8×	217 1.5×	110 0.9×	155 1.3×	44 0.4×	21	580
Shay Cahal United States	7	266 1.6×	276 1.9×	116 1.0×	166 1.4×	49 0.4×	22	640
Frank Rommel Germany	9	228 1.4×	44 0.3×	77 0.6×	98 0.8×	82 0.8×	15	448
J. Robert Kane United States	14	122 0.8×	115 0.8×	130 1.1×	208 1.7×	66 0.6×	20	607
Aafia Chaudhry United States	9	186 1.1×	141 1.0×	238 2.0×	91 0.8×	41 0.4×	49	542
Joseph Shan United States	10	113 0.7×	37 0.3×	83 0.7×	104 0.9×	137 1.3×	24	401
Jianghong Man China	13	105 0.6×	78 0.5×	182 1.5×	395 3.3×	75 0.7×	17	662
Viveka Nand Yadav United States	13	178 1.1×	42 0.3×	127 1.0×	187 1.5×	216 2.0×	27	538
Ignacio Gonzales-Gomez United States	8	86 0.5×	59 0.4×	139 1.1×	243 2.0×	61 0.6×	11	656
Hirokazu Kambara Japan	12	108 0.7×	76 0.5×	233 1.9×	313 2.6×	48 0.4×	17	694

Countries citing papers authored by Noa Kaynan

Since Specialization

Citations

This map shows the geographic impact of Noa Kaynan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noa Kaynan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noa Kaynan more than expected).

Fields of papers citing papers by Noa Kaynan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Noa Kaynan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noa Kaynan. The network helps show where Noa Kaynan may publish in the future.

Co-authorship network of co-authors of Noa Kaynan

This figure shows the co-authorship network connecting the top 25 collaborators of Noa Kaynan. A scholar is included among the top collaborators of Noa Kaynan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Noa Kaynan. Noa Kaynan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Voloshin, Tali, Lilach Koren, Yaara Porat, et al.. (2024). Abstract 4762: Tumor treating fields (TTFields) increase cancer cell membrane permeability and improve sensitivity to doxorubicin in vitro and in vivo. Cancer Research. 84(6_Supplement). 4762–4762. 3 indexed citations

2.

Voloshin, Tali, Lilach Koren, Yaara Porat, et al.. (2021). EXTH-74. INCREASING CANCER CELL MEMBRANE PERMEABILITY THROUGH APPLICATION OF TUMOR TREATING FIELDS (TTFIELDS). Neuro-Oncology. 23(Supplement_6). vi180–vi180. 1 indexed citations

3.

Brlić, Paola Kučan, Ilija Brizić, Berislav Lisnić, et al.. (2020). Cytomegalovirus protein m154 perturbs the adaptor protein-1 compartment mediating broad-spectrum immune evasion. eLife. 9. 10 indexed citations

4.

Voloshin, Tali, Noa Kaynan, Yaara Porat, et al.. (2020). Tumor-treating fields (TTFields) induce immunogenic cell death resulting in enhanced antitumor efficacy when combined with anti-PD-1 therapy. Cancer Immunology Immunotherapy. 69(7). 1191–1204. 114 indexed citations

5.

Voloshin, Tali, Rosa S. Schneiderman, Reuben R. Shamir, et al.. (2020). Tumor Treating Fields (TTFields) Hinder Cancer Cell Motility through Regulation of Microtubule and Actin Dynamics. Cancers. 12(10). 3016–3016. 63 indexed citations

6.

Voloshin, Tali, Noa Kaynan, Yaara Porat, et al.. (2020). Immunomodulatory effects of tumor treating fields (TTFields) on colon cancer models.. Journal of Clinical Oncology. 38(4_suppl). 136–136. 1 indexed citations

7.

Munster, Mijal, Rosa S. Schneiderman, Yaara Porat, et al.. (2019). Abstract 307: The combined treatment of 150 kHz Tumor Treating Fields (TTFields) and Cisplatin or Pemetrexed inhibit mesothelioma cells in vitro. Cancer Research. 79(13_Supplement). 307–307. 1 indexed citations

8.

Zeevi, Einav, Rosa S. Schneiderman, Mijal Munster, et al.. (2019). The Combined Treatment of 150 kHz Tumor Treating Fields (TTFields) and FOLFOX Inhibit Gastric Cancer in Vitro. International Journal of Radiation Oncology*Biology*Physics. 105(1). E681–E681. 1 indexed citations

9.

Weinberg, Uri, Noa Kaynan, Yaara Porat, et al.. (2019). Immunomodulatory effects of Tumor Treating Fields (TTFields) on lung cancer models. Annals of Oncology. 30. ii2–ii3. 5 indexed citations

10.

Munster, Mijal, Rosa S. Schneiderman, Yaara Porat, et al.. (2019). Efficacy of Tumor Treating Fields (TTFields) in Combination with Cisplatin or Pemetrexed for the Treatment of Mesothelioma in Vitro and in Vivo. International Journal of Radiation Oncology*Biology*Physics. 105(1). E679–E679. 1 indexed citations

11.

Voloshin, Tali, Yaara Porat, Anna Shteingauz, et al.. (2019). Immunomodulatory Effect of Tumor Treating Fields (TTFields) Results in Enhanced Antitumor Efficacy When Combined with Anti-PD-1 Therapy in Mouse Model of Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 104(1). 237–237. 2 indexed citations

12.

Shteingauz, Anna, Yaara Porat, Tali Voloshin, et al.. (2018). AMPK-dependent autophagy upregulation serves as a survival mechanism in response to Tumor Treating Fields (TTFields). Cell Death and Disease. 9(11). 1074–1074. 82 indexed citations

13.

Voloshin, Tali, Yaara Porat, Anna Shteingauz, et al.. (2018). IMMU-52. TUMOR TREATING FIELDS (TTFIELDS) INDUCE IMMUNOGENIC CELL DEATH RESULTING IN ENHANCED ANTITUMOR EFFICACY WHEN COMBINED WITH ANTI-PD-1 THERAPY. Neuro-Oncology. 20(suppl_6). vi133–vi133. 2 indexed citations

14.

Shteingauz, Anna, Yaara Porat, Tali Voloshin, et al.. (2018). CBMT-29. INDUCTION OF AUTOPHAGY FOLLOWING TTFIELDS APPLICATION SERVES AS A SURVIVAL MECHANISM MEDIATED BY AMPK ACTIVATION. Neuro-Oncology. 20(suppl_6). vi38–vi39. 2 indexed citations

15.

Porat, Yaara, Moshe Giladi, Rosa S. Schneiderman, et al.. (2017). Determining the Optimal Inhibitory Frequency for Cancerous Cells Using Tumor Treating Fields (TTFields). Journal of Visualized Experiments. 23 indexed citations

16.

Porat, Yaara, Moshe Giladi, Rosa S. Schneiderman, et al.. (2017). Determining the Optimal Inhibitory Frequency for Cancerous Cells Using Tumor Treating Fields (TTFields). Journal of Visualized Experiments. 46 indexed citations

17.

Weinberg, Uri, Tali Voloshin, Noa Kaynan, et al.. (2017). Efficacy of Tumor Treating Fields (TTFields) and anti-PD-1 in non-small cell lung cancer (NSCLC) preclinical models. Annals of Oncology. 28. ii11–ii12. 1 indexed citations

18.

Voloshin, Tali, Noa Kaynan, Moshe Giladi, et al.. (2017). Abstract 3665: Tumor Treating Fields (TTFields) plus anti-PD-1 therapy induce immunogenic cell death resulting in enhanced antitumor efficacy. Cancer Research. 77(13_Supplement). 3665–3665. 6 indexed citations

19.

Rovis, T., Paola Kučan Brlić, Noa Kaynan, et al.. (2016). Inflammatory monocytes and NK cells play a crucial role in DNAM-1–dependent control of cytomegalovirus infection. The Journal of Experimental Medicine. 213(9). 1835–1850. 42 indexed citations

20.

Yamin, Rachel, Noa Kaynan, Ariella Glasner, et al.. (2013). The Viral KSHV Chemokine vMIP-II Inhibits the Migration of Naive and Activated Human NK Cells by Antagonizing Two Distinct Chemokine Receptors. PLoS Pathogens. 9(8). e1003568–e1003568. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact